Major advances seen in 'non-small cell lung cancer' treatment Meghna A Singhania3 Jan 2016 4:15 PM ISTWashington: Although the most common type of lung cancer - non-small cell lung cancer (NSCLC) - has recently seen major treatment advances in some...
Triple therapy to help fight deadly lung cancer savita thakur thakur2 Jan 2016 11:08 AM ISTWashington: In experimental models of lung cancer, researchers have found that a combination of two drugs plus radiation can help treat resistant lung...
Europe recommends lung cancer drugs from AstraZeneca, Lilly savita thakur thakur19 Dec 2015 11:41 AM ISTThe European Medicines Agency said  its experts had recommended marketing approval for lung cancer drugs developed by AstraZeneca and Eli Lilly and...
Cancer on the rise in lower income countries : Study savita thakur thakur15 Dec 2015 12:46 PM ISTWASHINGTON: Many low-and middle-income countries have seen cancer rates rise, partially due to increases in risk factors that are typical of Western...
Roche gets accelerated U.S. approval for lung cancer drug Meghna A Singhania13 Dec 2015 2:55 PM ISTU.S. health regulators on Friday said they have granted accelerated approval to Roche Holding's drug for advanced lung cancer in patients with a...
FDA approves Genentech drug for advanced lung cancer savita thakur thakur13 Dec 2015 2:39 PM ISTThe Food and Drug Administration has approved an experimental Genetech drug for patients with a certain type of lung cancer who have few other...
FDA approves Portrazza to treat advanced squamous non-small cell lung cancer savita thakur thakur3 Dec 2015 3:02 PM ISTThe U.S. Food and Drug Administration approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced...
Over 800,000 lung cancer patients in China by 2020 savita thakur thakur2 Dec 2015 10:59 AM ISTBeijing: China is expected to have over 800,000 lung cancer patients diagnosed annually by 2020, with nearly 700,000 people dying from the disease...
Cipla weighs legal options after Delhi HC's patent ruling Meghna A Singhania29 Nov 2015 1:26 PM ISTNew Delhi: Drug major Cipla is exploring all legal options in the wake of Delhi High Court's ruling that it has infringed Swiss drug major Hoffman-La...
Cipla infringing Roche's patent in lung cancer drug: HC Pooja Bhatia Bhatia28 Nov 2015 9:49 AM ISTIn a setback to Cipla, the Delhi High Court today held that the Indian drug major was infringing Swiss pharmaceutical company Hoffman-La Roche's...
Merck's Keytruda extends survival in lung cancer study Meghna A Singhania27 Oct 2015 11:14 AM ISTMerck & Co's approved Keytruda lung cancer treatment provided superior overall survival to chemotherapy in a late-stage study of patients with...
FDA approves Bristol-Myers immunotherapy drug Opdivo Pooja Bhatia Bhatia11 Oct 2015 11:30 AM ISTBristol-Myers Squibb Co’s immunotherapy drug Opdivo has received the green signal from USFDA to treat an advanced form of lung cancer.The agency said...
